IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
JFL Life Sciences IPO is a Fixed Price IPO listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. GYR Capital Advisors is the merchant banker of JFL Life Sciences IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 12th April 2022.
JFL Life Sciences IPO open date is 25th August 2022 and close date is 30th August 2022. IPO Allotment Date is 5th September 2022 and Listing date is 8th September 2022.
IPO
Size:
₹ 18.17 Cr.
Avg IPO Size (Sector Based)
: ₹
21.21 cr.
Sector: Pharmaceutical
SME
IPO so far:
37
Merchant Banker:
GYR Capital
SME
IPO by BRLM so far:
39
City:
Ahmedabad
SME
IPO so far:
174
Revenue (annualised):
₹
27.96
cr. 
PE
Ratio:
26.52x
Average Sector PE Ratio: 20.29x
JFL Life Sciences IPO size is ₹ 18.17 Cr. with IPO price of ₹ 61.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
GYR Capital Advisors Private Limited is the book-running lead manager of the JFL Life Sciences IPO. Kfin Technologies Limited is the Registrar and Market Maker is Econo Broking Private Limited for JFL Life Sciences IPO.
JFL Life Sciences IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
JFL Life Sciences IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on Manufacturing of pharmaceutical products. The company is launching its SME IPO on the NSE EMERGE exchange, using the Fixed Price Issue method. JFL Life Sciences IPO size is ₹ 18.17 Cr. with fresh issue size of ₹ 18.17 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for JFL Life Sciences IPO is expected to be 5th September 2022, after the finalization of basis of allotment. Investors can check JFL Life Sciences IPO allotment status on the registrars website, Kfin Technologies Limited. JFL Life Sciences IPO refund dates are 6th September 2022.
JFL Life Sciences IPO is expected to be listed on 8th September 2022.
The upper price band for the JFL Life Sciences IPO is set at ₹ 61.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on JFL Life Sciences IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the JFL Life Sciences IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 30th August 2022. After submission, funds are blocked until the basis of allotment of JFL Life Sciences IPO is finalised.
The merchant banker for JFL Life Sciences IPO is GYR Capital Advisors Private Limited . GYR Capital Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the JFL Life Sciences IPO RHP for further details.
The registrar for JFL Life Sciences IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to JFL Life Sciences IPO through their official website or helpline.
JFL Life Sciences IPO was subscribed 8.93 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 18.17 Cr.
Avg IPO Size (Sector Based)
:
₹ 21.21 Cr.
Sector: Pharmaceutical
SME
IPO so far:
37
Merchant Banker:
GYR Capital
SME
IPO by BRLM so far:
39
City:
Ahmedabad
SME
IPO so far:
174
Revenue (annualised):
₹ 27.17 cr.
PE
Ratio:
26.52x
Average Sector PE Ratio: 20.29x
JFL Life Sciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on JFL Life Sciences Financial Review Page
Merchant Banker(s) of JFL Life Sciences IPO: GYR Capital Advisors Private Limited
JFL Life Sciences IPO subscription was 8.93 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
JFL Life Sciences IPO listed at a listing price of 66.50 against the offer price of 61.00.
The current market price of JFL Life Sciences is 18.75.
Why Us?
